NCT06629207 · RECRUITING
Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder
This study is tracking people who have REM sleep behavior disorder — a condition where people act out their dreams — to see if brain scans analyzed by AI can predict who will go on to develop Parkinson's disease or a related condition called Lewy body dementia. It is a non-drug observational study, not a treatment trial, so it is about building better prediction tools, not testing a therapy.
You may qualify if
- Confirmed clinical iRBD diagnosis by movement disorder specialists according to the International Classification of Sleep Disorders
- Written informed consent
You're excluded if
- Known diagnosis of PD or other neurodegenerative disorder
- Unequivocal signs of parkinsonism on examination
- Narcolepsy or other known causes of RBD
- Moderate to severe obstructive sleep apnea
- Abnormal neurological or MRI examination
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2024-11-08